Table 3 Efficacy and safety outcomes.
All | Up-front strategy | Bailout strategy | P-value | |
|---|---|---|---|---|
Bleeding BARC ≥ 3 | 17 (3.7) | 10 (4.8) | 7 (2.8) | 0.27 |
Bleeding BARC ≥ 2 | 41 (8.9) | 29 (13.8) | 12 (4.8) | 0.001 |
No bleeding (BARC 0) | 408 (88.9) | 171 (81.4) | 237 (95.2) | |
Bleeding BARC 1 | 10 (2.2) | 10 (4.8) | 0 | |
Bleeding BARC 2 | 24 (5.2) | 19 (9.0) | 5 (2.0) | |
Bleeding BARC 3 | 17 (3.7) | 10 (4.8) | 7 (2.8) | |
Unplanned revascularization | 9 (2.0) | 5 (2.4) | 4 (1.6) | 0.551 |
New ST-elevation following intervention | 5 (1.1) | 4 (1.9) | 1 (0.4) | 0.122 |
New myocardial infarction | 9 (2.0) | 8 (3.8) | 1 (0.4) | 0.009 |
Death (any cause) | 19 (4.1) | 8 (3.8) | 11 (4.4) | 0.745 |
Death (cardiovascular cause) | 2 (0.4) | 1 (0.5) | 1 (0.4) | 0.904 |
Death (unknown cause) | 17 (3.7) | 7 (3.3) | 10 (4.0) | 0.7 |
Stroke | 6 (1.3) | 3 (1.4) | 3 (1.2) | 0.833 |
